Mei‐Ren Pan

2.4k total citations
58 papers, 1.9k citations indexed

About

Mei‐Ren Pan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mei‐Ren Pan has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 31 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Mei‐Ren Pan's work include Epigenetics and DNA Methylation (14 papers), DNA Repair Mechanisms (7 papers) and Cancer Cells and Metastasis (7 papers). Mei‐Ren Pan is often cited by papers focused on Epigenetics and DNA Methylation (14 papers), DNA Repair Mechanisms (7 papers) and Cancer Cells and Metastasis (7 papers). Mei‐Ren Pan collaborates with scholars based in Taiwan, United States and Netherlands. Mei‐Ren Pan's co-authors include Wen‐Chun Hung, Wen-Chun Hung, Shiaw‐Yih Lin, Guang Peng, Ming‐Feng Hou, Ming‐Chuan Hsu, Hui‐Chiu Chang, Chi‐Wen Luo, Li‐Tzong Chen and Kaiyi Li and has published in prestigious journals such as Journal of Biological Chemistry, Nature Cell Biology and Cancer Research.

In The Last Decade

Mei‐Ren Pan

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei‐Ren Pan Taiwan 27 1.3k 691 410 186 167 58 1.9k
Cheng‐Chi Chang Taiwan 21 1.3k 1.0× 502 0.7× 478 1.2× 160 0.9× 66 0.4× 26 1.8k
Esther Castaño Spain 20 856 0.7× 401 0.6× 376 0.9× 157 0.8× 127 0.8× 49 1.6k
Jen-Liang Su Taiwan 27 1.8k 1.4× 863 1.2× 780 1.9× 275 1.5× 109 0.7× 35 2.5k
Karine Belguise France 19 806 0.6× 417 0.6× 372 0.9× 161 0.9× 63 0.4× 33 1.4k
Nicole R. Murray United States 26 1.4k 1.1× 637 0.9× 381 0.9× 178 1.0× 79 0.5× 47 2.1k
Janine Arts Netherlands 23 1.1k 0.9× 488 0.7× 251 0.6× 143 0.8× 64 0.4× 44 1.7k
Yasumichi Inoue Japan 22 1.2k 1.0× 544 0.8× 305 0.7× 176 0.9× 48 0.3× 56 1.8k
Amy Leung United States 23 1.4k 1.1× 370 0.5× 723 1.8× 325 1.7× 114 0.7× 46 2.2k
Sungman Park United States 11 906 0.7× 365 0.5× 287 0.7× 208 1.1× 95 0.6× 19 1.6k
Jiyun Yoo South Korea 23 1.2k 1.0× 413 0.6× 245 0.6× 129 0.7× 62 0.4× 53 1.8k

Countries citing papers authored by Mei‐Ren Pan

Since Specialization
Citations

This map shows the geographic impact of Mei‐Ren Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Ren Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Ren Pan more than expected).

Fields of papers citing papers by Mei‐Ren Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Ren Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Ren Pan. The network helps show where Mei‐Ren Pan may publish in the future.

Co-authorship network of co-authors of Mei‐Ren Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Ren Pan. A scholar is included among the top collaborators of Mei‐Ren Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Ren Pan. Mei‐Ren Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Chi‐Wen, Shu‐Jyuan Chang, Wangta Liu, et al.. (2024). Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer. Cancer Genomics & Proteomics. 21(5). 523–532. 3 indexed citations
2.
Huang, Wei-Lun, Yin-Chou Hsu, Chi‐Wen Luo, et al.. (2024). Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer. Life Sciences. 353. 122914–122914. 3 indexed citations
3.
Luo, Chi‐Wen, et al.. (2023). SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer Patients. Cancer Genomics & Proteomics. 20(6). 582–591. 4 indexed citations
4.
Pan, Mei‐Ren, Jun‐Ping Shiau, Chun‐Chieh Wu, et al.. (2023). Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer. Biomedicine & Pharmacotherapy. 163. 114732–114732. 10 indexed citations
5.
Luo, Chi‐Wen, Shih‐Feng Cho, Yi‐Chang Liu, et al.. (2023). Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer. Biomedicines. 11(3). 691–691. 2 indexed citations
6.
Wang, Hui‐Ching, Shih‐Feng Cho, Chun‐Chieh Wu, et al.. (2023). The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort. Biomedicines. 11(12). 3113–3113. 1 indexed citations
7.
Kuo, Chia‐Yu, Sin‐Hua Moi, Ming‐Feng Hou, Chi‐Wen Luo, & Mei‐Ren Pan. (2023). Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer. International Journal of Molecular Sciences. 24(6). 5583–5583.
8.
Wang, Hui‐Ching, Chi‐Wen Luo, Tzu-Yi Chen, et al.. (2022). Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway. Life Sciences. 311(Pt A). 121135–121135. 8 indexed citations
9.
Shiau, Jun‐Ping, Shu‐Jyuan Chang, Mei‐Ren Pan, et al.. (2021). FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer. Biomedicines. 9(12). 1789–1789. 35 indexed citations
10.
Moi, Sin‐Hua, et al.. (2021). RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. Journal of Personalized Medicine. 11(7). 655–655. 3 indexed citations
11.
Wang, Hui‐Ching, Chia‐Lin Chou, Ching‐Chieh Yang, et al.. (2019). Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy. International Journal of Molecular Sciences. 20(17). 4087–4087. 27 indexed citations
12.
Pan, Mei‐Ren, Ming‐Feng Hou, Fu Ou‐Yang, et al.. (2019). FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer. Journal of Clinical Medicine. 8(1). 38–38. 30 indexed citations
13.
Hsu, Ming‐Chuan, Chia‐Hsien Lin, Mei‐Ren Pan, et al.. (2019). Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer. Journal of Hematology & Oncology. 12(1). 79–79. 29 indexed citations
14.
Hou, Ming‐Feng, Chi‐Wen Luo, Wen‐Chun Hung, et al.. (2017). The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer. Experimental Cell Research. 359(2). 458–465. 24 indexed citations
15.
Huang, Chao‐Cheng, et al.. (2012). Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9. Clinical Cancer Research. 18(23). 6416–6425. 98 indexed citations
16.
Peng, Guang, Hui Dai, Wei Zhang, et al.. (2012). Human Nuclease/Helicase DNA2 Alleviates Replication Stress by Promoting DNA End Resection. Cancer Research. 72(11). 2802–2813. 64 indexed citations
17.
Pan, Mei‐Ren, et al.. (2009). Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells. Journal of Cell Science. 122(18). 3358–3364. 50 indexed citations
18.
Pan, Mei‐Ren, Ming‐Feng Hou, Hui‐Chiu Chang, & Wen‐Chun Hung. (2008). Cyclooxygenase-2 Up-regulates CCR7 via EP2/EP4 Receptor Signaling Pathways to Enhance Lymphatic Invasion of Breast Cancer Cells*. Journal of Biological Chemistry. 283(17). 11155–11163. 94 indexed citations
19.
20.
Hung, Wen‐Chun, et al.. (2000). Induction of p27KIP1 as a Mechanism Underlying NS398-Induced Growth Inhibition in Human Lung Cancer Cells. Molecular Pharmacology. 58(6). 1398–1403. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng‐Chi Chang Breakdown of academic impact, for papers by Esther Castaño Breakdown of academic impact, for papers by Jen-Liang Su Breakdown of academic impact, for papers by Karine Belguise Breakdown of academic impact, for papers by Nicole R. Murray Breakdown of academic impact, for papers by Janine Arts Breakdown of academic impact, for papers by Yasumichi Inoue Breakdown of academic impact, for papers by Amy Leung Breakdown of academic impact, for papers by Sungman Park Breakdown of academic impact, for papers by Jiyun Yoo
Rankless by CCL
2026